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Abstract
Background: Neuroinflammation plays an important role in neonatal hypoxic-ischemic encephalopathy (HIE).
Although microglia are largely responsible for injury-induced inflammatory response, they play beneficial roles in
both normal and disease states. However, the effects of microglial depletion on neonatal HIE remain unclear.
Methods: Tamoxifen was administered to Cx3cr1CreER/+Rosa26DTA/+ (microglia-depleted model) and
Cx3cr1CreER/+Rosa26DTA/− (control) mice at P8 and P9 to assess the effect of microglial depletion. The density of
microglia was quantified using Iba-1 staining. Moreover, the proportion of resident microglia after the HI insult was
analyzed using flow cytometric analysis. At P10, the HI insult was conducted using the Rice-Vannucci procedure at
P10. The infarct size and apoptotic cells were analyzed at P13. Cytokine analyses were performed using quantitative
polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) at P13.
Results: At P10, tamoxifen administration induced > 99% microglial depletion in DTA+ mice. Following HI insult,
there was persisted microglial depletion over 97% at P13. Compared to male DTA− mice, male DTA+ mice exhibited
significantly larger infarct volumes; however, there were no significant differences among females. Moreover,
compared to male DTA− mice, male DTA+ mice had a significantly higher density of TUNEL+ cells in the
caudoputamen, cerebral cortex, and thalamus. Moreover, compared to female DTA− mice, female DTA+ mice
showed a significantly greater number of TUNEL+ cells in the hippocampus and thalamus. Compared to DTA− mice,
ELISA revealed significantly lower IL-10 and TGF-β levels in both male and female DTA+ mice under both normal
conditions and after HI (more pronounced).
Conclusion: We established a microglial depletion model that aggravated neuronal damage and apoptosis after
the HI insult, which was predominantly observed in males.
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Background
Neonatal hypoxic-ischemic encephalopathy (HIE) is a
major worldwide cause of neonatal death and long-term
disability, including mental retardation, visual motor or
visual perceptive dysfunction, hyperactivity, cerebral
palsy, and epilepsy. HI insults are known to induce in-
flammatory reactions within hours in rodent models
with microglia playing an important role [1–5].
Microglia are resident cells in the brain that are the
first responders to ischemia. These cells engage in intim-
ate cross-talk with other intrinsic brain cells and infil-
trating leukocytes from the periphery that enter the
brain through the compromised blood-brain barrier
(BBB) [6–8]. In response to brain ischemia, microglia
initiate reactive oxygen species generation, antigen pres-
entation, phagocytosis, and the production of inflamma-
tory mediators, including interleukin (IL)-1β, tumor
necrosis factor (TNF)-α, IL-6, and matrix metallopro-
teinases [8–10]. Contrastingly, microglia plays an anti-
inflammatory role by producing factors such as IL-4, IL-
10, and transforming growth factor-β (TGF-β) during
the brain inflammation-resolution and on return to
homeostatic surveillance [10, 11]. There have been ex-
tensive studies on the active role of microglia in ische-
mic brain injury in the adult brain [12–17]. However,
the response to HIE largely differs between the adult
and neonatal brain [7, 18–21].
The specific role of microglia can be investigated using
microglial depletion models [22–32]. Most studies on
microglial depletion employ pharmacological strategies
involving the colony-stimulating factor 1 receptor
(CSF1R), including PLX33397 or PLX5622 [33]. How-
ever, this procedure requires at least 2 weeks for micro-
glia depletion. Therefore, there is a need for alternative
methods for assessing the role of microglia depletion in
neonatal HIE.
Neonatal HIE is known to show sexual dimorphism. A
previous study on 1,864,766 infants born in California
reported that males have a 1.27-fold higher risk (95% CI,
1.2–1.4) of HIE [34]. A previous study reported that ro-
dent models had no between-sex differences in the in-
farct size on the first day after HI; however, male
neonates presented significantly larger infarct sizes 3
days after HI [35]. Moreover, with respect to long-term
developmental outcomes, males are more vulnerable
than females [36, 37]. Similarly, there are sex differences
in the microglial number, morphology, migration, and
phagocytic activity [38–40].
We aimed to establish a model for studying the ef-
fects of microglial depletion on experimental neonatal
HIE, including the infarct size, apoptotic cells, and
cytokine response. Moreover, we aimed to determine




This study was approved by the ethics committee at Kar-
olinska Institutet, Stockholms Norra djurförsöksetiska
nämnd (approval number: N94/15 and N126/16) and
was conducted according to the relevant guidelines and
regulations (Swedish Animal Welfare Act 1988:543), as
well as the ARRIVE guidelines for animal experiments.
We used Cx3cr1EYFP-CreER mice, which express a Cre-
ERT2 fusion protein and enhanced yellow fluorescent
protein (EYFP), and Rosa26DTA+/- mice, which carry a
loxP-flanked stop cassette associated with an attenuated
diphtheria toxin [41]. Crossbreeding of these two strains
produced Cx3cr1CreER-EYFP+/Rosa26DTA+/− mice (DTA+
mice, microglia-depleted mice) and Cx3cr1 CreER-EYFP+/
Rosa26DTA−/− mice (DTA− mice, control mice) (Fig. 1a).
All the mice were housed in a humidity-controlled room
with a 12-h light-dark cycle and ad libitum access to
food and water.
Tamoxifen administration
Tamoxifen was purchased from Sigma-Aldrich (Cat.
#T5648), dissolved in corn oil (8 mg tamoxifen/1 ml corn
oil) at 70 °C, and intraperitoneally (50 mg/kg) injected to
the mice at P8 and P9.
Induction of hypoxic-ischemic encephalopathy
HIE induction was performed without knowing the
genotype. Unilateral HI was induced at P10 using the
modified Rice-Vannucci model [42–44]. After sedation
with isoflurane (4% for induction and 2% for mainten-
ance) and local anesthesia with Marcaine (Astra Zeneca),
the left common carotid artery was isolated and oc-
cluded through 8-Watt electronic coagulation (Figure
S1). The skin incision was sutured with 6-0 silk surgical
thread and infiltrated with additional local anesthesia.
All mice were subjected to ischemic surgery within < 5
min. Pups were returned to the dam for 1 h with subse-
quent placement in a hypoxic chamber (BioSpherix, NY,
USA) with 10% O2 in 90% N2 for 1 h. For mice in the
sham group, the carotid artery was isolated but not cau-
terized. For injury evaluation and cytokine analysis, 40
and 64 pups underwent the HI insult, respectively. The
sham group was included 41 pups.
Immunohistochemistry
The mice were anesthetized using an injection of 50 mg/
kg pentobarbital (APL, Sweden) and transcardially per-
fused with phosphate-buffered saline (PBS) followed by
4% paraformaldehyde (PFA) at P10, P13, P17, and P24
for a repopulation study and at P13 after HI for evalu-
ation of the infarction size. The removed brains were
fixed in 4% PFA for 24 h, dehydrated, embedded in a
paraffin block, and coronally sectioned to 5-μm-thick
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slices using a sliding microtome. Six levels of each brain
were collected as previously reported [18, 45, 46]. The
first level was obtained corresponding to the bregma 1.3
mm in the adult mouse brain with every 100th section
being collected and deparaffinized. After deparaffiniza-
tion, antigen retrieval was performed in 10mM citric
buffer (pH 6.0) for 10 min. After blocking, the sections
were exposed to primary antibodies in a humidity cham-
ber box overnight at 4 °C. The primary antibodies were
those against rabbit Iba-1 obtained from Wako
(#1919741) and diluted at 1:1000, mouse microtubule-
associated protein-2 (MAP-2) obtained from Sigma
(#M4403) and diluted at 1:1000, rabbit anti glial fibrillary
acidic protein (GFAP) diluted at 1:500 (#ab5804),
chicken anti-green fluorescent protein obtained from
Abcam (#ab13970) and diluted at 1:500, and mouse anti
myelin basic protein (MBP) obtained from Covance and
diluted 1:1000. After washing, biotin-conjugated donkey
anti-rabbit secondary antibody (Jackson ImmunoRe-
search) diluted at 1:1000 was applied for Iba-1 while the
VECTOR M.O.M.™ Immunodetection Kit was used for
MAP-2. After blocking endogenous peroxidase using
0.3% H2O2, the sections were visualized using the VEC-
TASTAIN Elite ABC-Peroxidase Kit and 3,3′-diamino-
benzidine. For GFAP, biotinylated donkey anti-rabbit
secondary antibody was applied for 1 h prior to incuba-
tion with VECTASTAIN® Elite ABC-Peroxidase Kit. For
immunofluorescence analyses, the following secondary
antibodies were used: donkey anti-rabbit IgG Alexa
Fluor 555 (1:1000) and donkey anti-chicken Alexa Fluor
488 (1:1000). Nucleus staining was performed using
Hoechst 33342 (1:1000, ThermoFisher). Coverslips were
mounted onto slides using antifade reagent ProLong
Gold (Molecular probes/Life technologies).
Iba-1+ cell counting
Sections were examined using Zeiss Axio Imager M2
(Carl Zeiss, Göttingen, Germany). The microglia number
was determined by counting the Iba-1-positive cells in
the whole hemisphere. The total Iba-1+ cell number was
calculated using the fractionator option in Stereo Inves-
tigator software (MicroBrightField, Colchester, Vt.,
USA). Briefly, each section was divided into 200 approxi-
mately equal squares (400 × 400 μm, sampling grid).
Subsequently, the number of Iba-1+ cells with a
complete cell body was counted in each 100 × 100 μm
red-green square (counting frame) using a × 20 air ob-
jective. The software allowed estimation of the total cell
number and the whole coronal section area. Slides from
the DTA+ mice at P10, P13, and P17 showed few un-
evenly distributed microglial cells; therefore, all the Iba-
1+ cells were directly counted without using a fraction-
ator. Based on these data, the Iba-1+ cell density was
calculated.
Fluorescence-activated cell sorting
Mice were sacrificed using an intraperitoneal injection of
50 mg/kg pentobarbital (APL, Sweden) and transcardially
perfused with PBS. After 5 min of perfusion, the brains
were extracted and the olfactory bulbs and cerebellum
removed. Subsequently, the right and left hemispheres
were separated and individually processed. Next, the tis-
sue was minced with a scalpel and digested for 30 min at
37 °C with Hank’s Balanced Salt Solution (HBSS) con-
taining 0.02% DNase 1 (Sigma-Aldrich) and 0.005% col-
lagenase (Sigma-Aldrich). The reaction was stopped
using cold HBSS containing 0.01% ethylenediaminetetra-
acetic acid (EDTA); subsequently, the samples were
strained and centrifuged at 4 °C (300g, 10 min). The pel-
lets were resuspended in 38% percoll solution and cen-
trifuged at 4 °C (800g, 10 min). After careful removal of
the supernatant, the pellets were rinsed with PBS and
transferred to a V-bottom plate for staining. The sam-
ples were incubated for 20 min at 4 °C with PBS contain-
ing CD11b (1:100, M1-70, BioLegend), CD45 (1:1000,
30-F11, BioLegend), and LIVE/DEAD™ Fixable Near-IR
Dead Cell Stain Kit (Invitrogen) and rinsed before ana-
lysis. The cell numbers were determined using the Gal-
lios flow cytometer (Beckman Coulter) and analyzed
using Kaluza software (Beckman Coulter).
Injury evaluation
At P13, tissue loss was assessed by determining the
MAP-2-stained area as previously described [18, 45].
First, the MAP-2-positive area was separately measured
in each hemisphere using Stereo Investigator software
(MicroBrightField, USA). Second, the difference in the
areas was calculated by subtracting the staining area in
the contralateral hemisphere from that in the ipsilateral
hemisphere. Next, the total tissue loss volume was calcu-
lated based on the Cavalieri principle using the following
formula: V = ΣA·P·T (where V is the total volume, ΣA is
the sum of the areas measured, P is the inverse of the
sampling fraction, and T is the section thickness). This
evaluation was performed with genotype blinding.
(See figure on previous page.)
Fig. 1 Microglial depletion and repopulation following tamoxifen (TAM) administration. a Scheme of the genetic design. b Scheme of the
repopulation study. c Representative Iba-1 staining slides for microglia in the striatum level at each time point. Scale bar indicates 200 μm in the
upper column and 50 μm in the lower column. The square in the upper column indicates higher magnification in the lower column. d The Iba-
1+ cell density in the striatum level and hippocampus level in male mice. e The Iba-1+ cell density in the hippocampus level in female mice
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TUNEL and NeuN double staining
After deparaffinization, antigen retrieval was performed
in 10mM citric buffer (pH 6.0) for 15 min. The sections
were incubated with 5% normal donkey serum and 0.3%
Triton X-100 in PBS for 30 min at room temperature
followed by rabbit monoclonal anti-NeuN antibody (1:
100, MABN140, Millipore Corpo, CA, USA) at 4 °C
overnight. After washing out the primary antibody, don-
key anti-rabbit Alexa Fluor 488 (1:300, A-212206,
Thermo Fisher Scientific) was applied for 2 h at room
temperature. The sections were rinsed with PBS
followed by the terminal deoxynucleotidyl transferase-
dUTP nick end labeling (TUNEL) (Click-iT Plus TUNEL
Assay Kit, C10618, Thermo Fisher Scientific Europe BV)
assay according to the manufacturer’s protocol. Stereo-
logical analysis was performed using Stereo Investigator
software (MicroBrightField, USA). The number of
TUNEL+ cells was counted under × 20 magnification
[47, 48]. First, each region’s contour (striatum, hippo-
campus, cortex, and thalamus) was traced using a × 5 air
objective. The counting frame and grid size were both
set to 150 × 150 μm, and the number of TUNEL-
positive cells was counted using a × 20 air objective. Cell
counting was performed by an investigator blinded to
the genotype. Fluorescent images were obtained using a
LSM700 laser scanning confocal microscope (Axio-ob-
server Z1; Carl Zeiss microscopy, Germany) and ana-
lyzed using the software ZEN 2.3 (blue edition; Zeiss).
Genotyping
Post-sacrifice genotyping was performed using a piece of
tissue that was placed in 75 μl extraction buffer contain-
ing 25 mM sodium hydroxide and 0.2 mM EDTA in dis-
tilled water and incubated at 98 °C for 60 min. Next,
75 μl of 40 mM tris-hydroxymethyl aminomethane-
hydrochloric acid (pH 5.0) was added and centrifuged at
6000 revolutions per minute (rpm) for 3 min. The super-
natant was collected for genotyping. Regarding the poly-
merase chain reaction (PCR), 2 μl of cDNA was mixed
with 0.25 μl of MyTaq™ HS DNA Polymerase, 10 μl of 5x
MyTaq™ Reaction Buffer (Bioline meridian, London,
UK), 3 μl of each of the corresponding primers (0.5 μM),
and 34.75 μl of distilled water (total 50 μl). Table S1
shows each primer sequence. The Cre allele was ampli-
fied using 30 cycles of 95 °C for 30 s, 61.5 °C for 30 s, and
72 °C for 60 s. For the DTA allele, there were 35 cycles
of 94 °C for 30 s, 60 °C for 60 s, and 72 °C for 60 s. The
PCR products were separated on 1% agarose gel and
stained with GelRed® Nucleic Acid Gel Stain (Biotium,
Inc. Fremont, CA, USA).
Fig. 2 At P14, there was persisted microglial depletion following HI at P10. a Gating strategy for FACS analysis. After dead cell elimination, first
gating was defined as CD11b+CD45+ while resident microglial cells were defined by CD11b+CD45+EYFP+ status. b Quantification of resident
microglial cells in males for each group (DTA− HI group, n = 7; DTA+ HI group, n = 5; DTA− sham group, n = 3; DTA+ sham group, n = 3). c
Quantification of resident microglial cells in females in each group. (DTA− HI group, n = 8; DTA+ HI group, n = 3; DTA− sham group, n = 4; DTA+
sham group, n = 3) **P < 0.01, ***P < 0.001, ****P < 0.0001; one-way ANOVA followed by the Sidak test. Bars reflect mean ± SD
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Quantitative polymerase chain reaction
Total RNA was isolated from the ipsilateral hemisphere
after HI using the RNeasy Kit (QIAGEN) and measured
using a NanoDrop (Thermo Scientific). All the samples
had a nucleotide ratio (A260: A280) within the range of
1.9–2.1. A total of 1 μg of extracted RNA underwent re-
verse transcription into cDNA using the iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA, USA) according
to the manufacturer’s protocol. Quantitative PCR
(qPCR) was performed using the Step-One-Plus Real-
Time PCR machine (Applied Biosystems) with Power
SYBR Green PCR Master Mix (Applied Biosystems)
and the primers presented in Table S2. The set-up
condition was initial denaturation at 95 °C for 5 min,
subsequent denaturation at 95 °C for 5 s, annealing at
60 °C for 10 s, and elongation for 30 s for a total of
40 cycles. The cycle time values were normalized to
the β-actin of the same sample. The mRNA expres-
sion levels were calculated using the delta-delta CT
method as fold changes compared to the DTA− sham
samples at P13. For pre-HI insult assessments, DTA+
samples were compared with DTA− samples at P10
after tamoxifen administration at P8 and P9. All sam-
ples were examined in triplicate. The aforementioned
analyses were performed using the StepOne software
program (version 2.3, Applied Biosystems).
Fig. 3 Evaluation of infarct size through MAP-2 staining at P13 following HI insult at P10. a The experimental design. b The ratio of body weight
change in this experiment. c Representative slides of MAP-2 staining in male and female DTA− and DTA+ mice. The upper and lower row shows
the striatum and hippocampus level, respectively. The scale bar indicates 500 μm. d, e Quantification of infarct volume in DTA− and DTA+ mice of
each gender, as well as males and females of each genotype (DTA− male, n = 12; DTA+ male, n = 10; DTA− female, n = 6; DTA+ female, n = 12;
no tamoxifen male, n = 6; no tamoxifen female n = 9) *P < 0.05; two-way ANOVA followed by the Bonferroni multiple comparison test
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Quantitative enzyme-linked immunosorbent assay
Ipsilateral hemispheres were collected from the pups at
P13 after administering the HI insult at P10. Tissue sam-
ples were homogenized in N-PER™ Neuronal Protein Ex-
traction Reagent (Thermo Fisher) with cOmplete™, Mini,
EDTA-free Protease Inhibitor Cocktail (Sigma-Aldrich)
using pellet pestles, blue polypropylene (Sigma-Aldrich)
on ice. After 1-h agitation at 4 °C, lysates were centri-
fuged at 14000 rpm for 10 min. The supernatant’s pro-
tein concentration was measured using the Pierce BCA
Protein Assay kit (Thermo Scientific) according to the
manufacturer’s protocol. Lysate aliquots were stored at
− 80 °C for subsequent analysis. After the preparation of
all the samples, the IL-10 and TGF-β levels in the lysates
were measured using Mouse IL-10 Quantikine ELISA
Kit (R&D system) and Mouse/Rat/Porcine/Canine TGF-
beta 1 Quantikine ELISA Kit (R&D system). For TGF-β
assessments, the samples were treated with 1N HCL
to activate the latent TGF-β before measurement
using an ELISA kit. The optical density was deter-
mined at 450 nm using a microplate reader (FLUOstar
Omega, BMG LABTECH, Germany) within 15 min
after stopping the reactions. All measurements were
performed in duplicate.
Statistical analysis
Values are presented as mean ± standard deviation. Stat-
istical analysis was performed using GraphPad Prism
ver. 7 (GraphPad Software, Inc., San Diego, CA, USA).
One-way ANOVA was used for multiple comparisons
followed by the Sidak test for determining statistical sig-
nificance. Moreover, we performed two-way ANOVA
with the Bonferroni multiple comparison test as the post
hoc test. In non-normally distributed data, Kruskal-
Wallis test was used followed by the Dunn’s comparison
to be consistent with the results as non-parametric test.
Statistical significance was defined at P < 0.05.
Results
Microglial depletion and repopulation using tamoxifen in
Cx3cr1CreERRosa26DTA neonatal mice
After tamoxifen administration at P8 and P9, Iba-1+ cells
were counted at P10, P13, P17, and P24 to evaluate
microglia depletion and repopulation (Fig. 1b). At P10,
over 99% of the microglia was eliminated in both sexes
(striatum and hippocampus level) without significant sex
differences. At P13, male DTA+ mice had 1% microglia
at the striatum level and 2% at the hippocampus level in
comparison with DTA− mice. Similarly, female DTA+
mice had 1% microglia at both levels compared to DTA−
mice. However, there was rapid microglia repopulation
by P17. Both male and female DTA+ mice showed
microglial repopulation of up to approximately 60% at
the striatum level and 70% at the hippocampus level;
however, there were between-group differences in these
ratios. At P24, there was complete microglia repopula-
tion in mice of both sexes at both the striatum and
hippocampus levels (Fig. 1c-e).
Microglial depletion persisted after the HI insult
At P13, we performed fluorescence-activated cell sorting
(FACS) analyses using surface markers to determine the
post-HI depletion status. We defined resident microglia
as CD11b+CD45+EYFP+ cells and examined their ratio
over the total live cell number (Fig. 2a). At P13, there
were no sex differences in the differences between
DTA− and DTA+ mice in both the ipsilateral and contra-
lateral sides of the brain after HI and in the sham group
(Fig. 2b, c). Moreover, we performed immunohistochem-
istry to confirm microglia depletion and EYFP colocali-
zation. We observed very few Iba-1+ cells in DTA+ mice
with most being colocalized with EYFP (Figure S2).
These findings suggested microglia depletion 3 days after
HI and 4 days after the second and last tamoxifen
injection.
Microglial depletion aggravated the post-HI infarction
size in male mice
To assess the effect of microglia in neonatal brain injury,
we performed HI at P10 after microglial depletion. The
mice were sacrificed at P13 and genotyped (Fig. 3a). All
the DTA groups showed stagnated weight gain during
tamoxifen administration compared to the non-treated
groups (Fig. 3b); moreover, there was no mortality at
P13. Neuronal damage was evaluated by MAP-2 staining
(Fig. 3c). There was a significant difference in tissue loss
between male DTA− and DTA+ mice (Fig. 3d) and be-
tween male and female DTA+ mice (Fig. 3e). Further,
GFAP staining showed higher gliosis in DTA+ mice than
in DTA - mice (Figure S3).
(See figure on previous page.)
Fig. 4 TUNEL and NeuN staining at P13 following HI insult at P10. a Representative image of co-immunofluorescent staining at the striatum level.
The scale bar indicates 500 μm. b High magnification of the TUNEL+ area at the striatum level in each gender and genotype in the square shown
in Fig. 1. Scale bar indicates 20 μm. c Quantification of TUNEL+ cells/mm2 in the caudoputamen and cerebral cortex. d Comparison of sex
differences within the same genotype. The number of TUNEL-positive cells in each interest region at P13 following HI insult at P10 (DTA− male, n
= 12; DTA+ male, n = 10; DTA− female, n = 6; DTA+ female, n = 12) **P < 0.01, ***P < 0.001. For the caudoputamen, two-way ANOVA was
performed followed by the Bonferroni multiple comparison test. For the cerebral cortex, the Kruskal-Wallis test was performed followed by Dunn’s
multiple comparison test. Bars depict mean ± SD
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Post-HI microglial depletion aggravated neuronal
apoptosis
TUNEL and NeuN staining was performed in the same
sections as those used for MAP-2 evaluation at P13 to
assess the microglia effects on neuronal TUNEL-related
apoptosis. At both the striatum and hippocampus levels,
the TUNEL+ cluster area matched the areas without
NeuN (Fig. 4a, Figure S4a) and MAP-2 (Fig. 3c) staining.
High magnification demonstrated the co-localization of
TUNEL+ and NeuN+ cells (Fig. 4b). Among the male
mice, DTA+ mice showed a significantly greater
TUNEL+ cell density than that in DTA− mice in the cau-
doputamen, cerebral cortex, and thalamus (Fig. 4c,
Figure S4b). Among females, DTA+ mice showed a sig-
nificantly greater TUNEL+ cell density than that in
DTA− mice in the hippocampus and thalamus (Figure
S4b). Assessment of sex differences in parallel genotypes
showed a tendency of exacerbated apoptosis among
males compared to that in females except for in the
hippocampus (Fig. 4d, S4c).
Post-HI inflammation-related gene expression at P13
To investigate whether microglial depletion has an effect
on pro- and anti-inflammatory cytokine expression at P13
following HI at P10, we performed quantitative PCR using
homogenates of the ipsilateral hemisphere. Among males,
there was significantly suppressed IL-10 and TGF-β gene
expression in the DTA+ HI group compared to in the
DTA− HI group (Fig. 5a). There were no differences in IL-
1β, TNF-α, iNOS, and IL-4 expressions (Fig. 5a). Among
females, only TGF-β expression showed a significant differ-
ence between the DTA− HI and DTA+ HI groups (Fig. 5b).
Contrastingly, there were no differences in inflammatory
and anti-inflammatory cytokine expression at P10 following
tamoxifen administration at P8 and P9 (Figure S5a).
Microglial depletion attenuated IL-10 and TGF-β protein
levels
Based on the quantitative PCR results, the IL-10 and TGF-
β protein levels were measured using ELISA in the ipsilat-
eral hemispheres at P13 following HI at P10. Compared to
male mice in the DTA+ group, those in the DTA− group
showed higher IL-10 expression levels (Fig. 6a). There were
significant differences in the TGF-β levels between the
DTA− and DTA+ groups comprised of both sham and HI
mice (Fig. 6a). Moreover, female mice in the DTA− and
DTA+ groups comprised of both sham and HI mice had
significantly different IL-10 and TGF-β expression levels
(Fig. 6b). We observed sex differences in IL-10 expression
regardless of genotype. Moreover, male mice in the DTA−
group showed higher TGF-β expression compared to fe-
male mice in this group. However, there were no corre-
sponding sex differences between male and female mice in
the DTA+ group (Fig. 6c).
Discussion
In this study, we report a microglial depletion model in
early postnatal life that aggravated neuronal damage
after HI injury. Microglial depletion reduced IL-10 and
TGF-β levels both under normal and post-HI (more pro-
nounced) conditions. There was a sex-specific sensitivity
where males were more affected than females.
To our knowledge, this is the first report on the effect
of microglia in neonatal HIE using a neonatal genetic
microglial-depletion model. We recently demonstrated
competitive CNS repopulation following microglia de-
pletion and the development of fatal demyelinating
disease using an acute microglial-depletion Cx3cr1CreER-
Rosa26DTA model [23, 41]. This genetic microglial-
depletion model is suitable for neonatal experiments.
Furthermore, we did not observe found BBB disruption
after microglial depletion [41]. However, this genetic
model requires tamoxifen administration for microglia
depletion. Tamoxifen has a neuroprotective effect in-
volving inhibition of neuronal nitric oxidase synthase,
scavenging of reactive oxygen species, and the estrogen
effect [49, 50]. Despite these model limitations, we be-
lieve that they caused an insignificant bias between the
DTA− and DTA+ groups given that both groups received
similar tamoxifen doses.
Previous studies have employed microglial-depletion
models of adult stroke, Alzheimer’s disease, and retinal
disease [26, 28, 30, 33, 51, 52]. To study the early-life
role of microglia, an acute microglial depletion model
was required. Intracerebral administration of clodronate
encapsulated into liposomes (Clod-lip) has been shown
to immediately induce microglia depletion [53]. How-
ever, this method causes unselective cell damage, includ-
ing blood vessel damage and incomplete depletion [22,
33]. Among adult mice, Cx3cr1CreERRosa26DTR mice
(See figure on previous page.)
Fig. 5 Pro- and anti-inflammatory gene expression at P13 following HI insult at P10. Relative expression of pro-inflammatory (IL-1β, TNF-α, and
iNOS) and anti-inflammatory genes (IL-4, IL-10, and TGF-β) was measured by quantitative PCR at P13 in males (a) (DTA− sham, n = 3; DTA+ sham,
n = 4; DTA− HI, n = 6; DTA+ HI, n = 9) and females (b) (DTA− sham, n = 3; DTA+ sham, n = 3; DTA− HI, n = 6; DTA+ HI, n = 6). All values were
normalized to β-actin. The expression levels of the target mRNAs were calculated and compared with the DTA− and sham groups. Values are
presented as mean ± SD. *P < 0.05, **P < 0.01. Regarding TNF-α, iNOS, IL-4, and TGF-β expression in males and IL-1β, iNOS, IL-4, and TGF-β
expression in females; one-way ANOVA followed by the Sidak multiple comparison test. Regarding IL-β and IL-10 in males and TNF-α and IL-10 in
females; Dunn’s multiple comparison test
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Fig. 6 (See legend on next page.)
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have been reported as an acute microglial depletion model
through tamoxifen administration with subsequent diph-
theria toxin administration [31, 54]. To avoid administer-
ing pups with multiple injections, we employed the
Cx3cr1CreERRosa26DTA strain.
First, we confirmed microglia depletion and repopula-
tion in our neonatal model. At P10, compared with
DTA− mice, the efficiency of resident microglial deple-
tion was > 99% in DTA+ mice. This depletion status
remained until at least P13. At P17, we observed micro-
glia repopulation clusters (Figure S6), which is consistent
with previous findings on adult microglial depletion
models [54]. These clusters were few and asymmetrically
distributed throughout the brain. This asymmetrical dis-
tribution could induce significant result variations if the
analysis is conducted during repopulation; therefore, we
evaluated brain damage at P13. Compared to the DTA-
p24 mice, there was a numerical, but not significant,
higher repopulation in the DTA+p24 mice. This is con-
sistent with a previous report that the number of repo-
pulated microglia at day 7 was higher after the
withdrawal of a selective CSF1R inhibitor than in the
normal brain [24]. We assumed that the proliferation
ability of repopulated microglia was higher than that of
normal microglia. Next, we confirmed that these deple-
tion conditions remained after HI. We identified resi-
dent microglia with EYFP using FACS and recorded a
high depletion rate (97%) after 4 days (P13), which cov-
ered the time period of the HI insult and recovery. Subse-
quently, we confirmed microglia depletion and EYFP
colocalization through immunohistochemistry (Figure S2).
To assess the exclusive effect of microglial depletion, we
conducted the quantitative PCR of the brain after tamoxi-
fen administration. Figure S5a shows that there was no
difference between DTA− and DTA+ mice; however,
DTA+ mice showed a tendency of lower IL-1β expression
compared to DTA− mice. Further, we stained astrocytes in
both mice groups using GFAP for slides after tamoxifen
administration at P8 and P9. Moreover, Figure S5b
showed no between-group differences in the astrocytes.
Given that there was little between-genotype differ-
ence in the inflammation and astrocyte reaction before
the HI insult, our findings indicate that microglial deple-
tion could lead to aggravation of neuronal damage and
astrocyte reaction (Fig. 3, Figure S3). Regarding oligo-
dendrocytes, we observed MBP loss in the striatum but
not the hippocampus level of the DTA+ mice (Figure
S7). This is consistent with previous findings of a
neonatal depletion model using Clod-lip, which demon-
strated that microglia depletion increased the brain in-
jury severity and volume through middle cerebral artery
occlusion (MCAO) [53]. Moreover, an adult depletion
model demonstrated that microglia depletion enhances
the post-MCAO size of ischemic brain injury at 24 h
[26]. Further, our findings indicated a sex difference in
the effect of microglial depletion after HIE. Only males
showed a significant difference in the MAP-2 evaluation
of the brain injury after microglia depletion. TUNEL
staining showed sex-specific effects on different regions.
There have been several reports regarding sex- and
region-specific effects following HI insult from the per-
spective of mitochondrial metabolism and apoptotic
mechanism [55–57]. Further, there have been previous
reports on sex differences in the microglia number and
function [40, 58]. These overall differences might con-
tribute toward TUNEL staining differences. There have
been recent studies on sex differences in brain inflam-
mation and microglial effects [38–40]. For example,
microglia in males have been reported to have higher
migrational capacity than those in females, which could
be related to the protective effect of microglia depletion
[40]. Alternatively, the sex differences in our model
could be attributed to the estrogen effect of tamoxifen.
Estrogen has neuroprotective effects in the ischemic
brain, which are stronger in females given the more ef-
fective estrogen receptor upregulation [59–61].
Previous studies on microglial depletion in adult
stroke models reported significantly increased inflamma-
tory mediator levels in injured tissues at 24 h following
MCAO [26]. In our study, analyses at 72 h after the in-
jury showed no significant differences in the levels of
several pro-inflammatory cytokines. This could be attrib-
uted to our experimental design of the evaluation of
pro-inflammatory cytokines at the end of the sub-acute
phase [3, 62]. We found differences in the anti-
inflammatory cytokines between DTA− and DTA+ mice.
We found suppressed IL-10 upregulation and TGF-β
downregulation in microglia-depleted mice 3 days after
the HI insult. Microglia have been shown as a major
post-stroke source of TGF-β [63]. To confirm these
quantitative PCR results at the protein level, we con-
ducted ELISA for IL-10 and TGF-β and found that they
were significantly decreased in the DTA+ and sham
group (Fig. 6a, b). With respect to sex differences in IL-
10, there was a tendency of lower expression in males
than in females regardless of the genotype (Fig. 6c).
(See figure on previous page.)
Fig. 6 ELISA quantification of IL-10 and TGF-β protein levels at P13 following HI insult at P10. a Males (DTA– sham, n = 7; DTA+ sham, n = 10;
DTA− HI, n = 9; DTA+ HI, n = 9). b Females (DTA− sham, n = 4; DTA+ sham, n = 7; DTA− HI, n = 9; DTA+ HI, n = 10). c Comparison of sex
differences within the same genotype. *P < 0.05, **P < 0.01, ***P < 0.001. Kruskal-Wallis test followed by Dunn’s multiple comparison test. Bars
depict mean ± SD
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Interestingly, we did not detect IL-10 in microglia elimi-
nated male model. These findings suggest that IL-10
production is dependent on microglia in males. With re-
spect to TGF-β, there were sex differences in the DTA−
mice and DTA+ mice (Fig. 6c), which suggested that
TGF-β is mainly dependent on microglia especially in
males. Previous studies have also indicated that micro-
glia is a major source of locally produced TGF-β after
HI insult [63]. However, consistent with our findings,
other cells have been reported to be produced after
microglia depletion [64]. Taken together, our findings
indicate that microglial depletion aggravates neuronal
death due to a lack of anti-inflammatory cytokines.
However, other sex-related mechanisms may inhibit
neuronal damage in females, including the mitochon-
drial respiratory capacity of astrocytes, as well as the dif-
ferent contribution of TGF-β by resident microglia [55,
65, 66]. Consistent with our findings, Jin reported that
microglial depletion increased ischemia-induced astro-
cytic inflammatory response and neural injury [26].
Therefore, assessing astrocytic responses is a potential
avenue to understand the impact of microglia depletion
in neonatal hypoxic-ischemic mice.
Conclusions
In this study, we established a model of 99% microglial de-
pletion in neonatal mice. Our findings indicate that resi-
dent microglia play a neuroprotective role early after
neonatal hypoxic ischemia, which is predominant in males
with the protective effect involving anti-inflammatory
cytokines.
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Additional file 1: Figure S1. Occlusion procedure by electronic
coagulation of the left common carotid artery. a Separation from the
vagus nerve. b The artery was grasped by bipolar electronic micro
forceps. c Coagulation by bipolar electronic micro forceps. d Occlusion
by electronic coagulation.
Additional file 2: Figure S2. Representative slide for microglia
depletion and Iba-1+/Cx3Cr1-EYFP+ cell co-localization at P13 after HI at
P10. The scale bar in high magnification is 20 μm.
Additional file 3: Figure S3. Representative GFAP staining slides. a
Low magnification in DTA− and DTA+ mice of both genders. The upper
row shows the striatum level while the lower row shows the
hippocampus level. Scale bar indicates 500 μm. The square indicates the
higher magnification. b High magnification of GFAP staining. Scale bar
indicates 100 μm.
Additional file 4: Figure S4. TUNEL and NeuN staining at P13 following
HI insult at P10. a Representative image of co-immunofluorescent staining at
the hippocampus level. Scale bar indicates 500 μm. b Quantification of TUNEL+
cells/mm2 in the hippocampus and thalamus. c Comparison of sex differences
within the same genotype. The number of TUNEL positve cells in each interest
region at P13 following HI insult at P10. (DTA− male, n = 12; DTA+ male, n =
10; DTA− female, n = 6; DTA+ female, n = 12) *P < 0.05, ****P < 0.001. The
Kruskal-Wallis test followed by Dunn’s multiple comparison test. Bars depict
mean ± SD.
Additional file 5: Figure S5. a Cytokine analysis at P10 after tamoxifen
administration at P8 and P9. (DTA− male, n = 5; DTA+ male, n = 3; DTA−
female, n = 4; DTA+ female, n = 4) Bars depict mean ± SD. b GFAP
staining at P10 after tamoxifen administration at P8 and P9. CA; cornu
ammonis DG; dentate gyrus.
Additional file 6: Figure S6. Uneven repopulation at P17 following
tamoxifen administration at P8 and P9. a There was an equal number of
Iba-1 staining cells in the whole in DTA− mice. b In the DTA+ mice, there
was partial detection of Iba-1 staining cells with uneven distribution.
Scale bar indicates 500 μm.
Additional file 7: Figure S7. Representative slides of MBP staining. a
Striatum level. b Hippocampus and thalamus level. Cont; contralateral
side (healthy side) Ipsi; Ipsilateral side (injury side). Scale bar indicates
500 μm.
Additional file 8: Table S1. Genotyping Primer.
Additional file 9: Table S2. qPCR Primer.
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